Suppr超能文献

数字化连通性:第六生命体征。

Digital Connectivity: The Sixth Vital Sign.

机构信息

Mills-Peninsula Medical Center, San Mateo, CA, USA.

Diabetes Technology Society, Burlingame, CA, USA.

出版信息

J Diabetes Sci Technol. 2022 Sep;16(5):1303-1308. doi: 10.1177/19322968211015241. Epub 2021 May 12.

Abstract

Digital health and telehealth connectivity have become important aspects of clinical care. Connected devices, including continuous glucose monitors and automated insulin delivery systems for diabetes, are being used increasingly to support personalized clinical decisions based on automatically collected data. Furthermore, the development, demand, and coverage for telehealth have all recently expanded, as a result of the COVID-19 pandemic. Medical care, and especially diabetes care, are therefore becoming more digital through the use of both connected digital health devices and telehealth communication. It has therefore become necessary to integrate digital data into the electronic health record and maintain personal data confidentiality, integrity, and availability. Connected digital monitoring combined with telehealth communication is known as virtual health. For this virtual care paradigm to be successful, patients must have proper skills, training, and equipment. We propose that along with the five current vital signs of blood pressure, pulse, respiratory rate, temperature, and pain, at this time, digital connectivity should be considered as the sixth vital sign. In this article, we present a scale to assess digital connectivity.

摘要

数字健康和远程医疗连接已成为临床护理的重要方面。连接设备,包括用于糖尿病的连续血糖监测仪和自动胰岛素输送系统,正越来越多地被用于根据自动收集的数据支持个性化的临床决策。此外,远程医疗的发展、需求和覆盖范围最近都因 COVID-19 大流行而扩大。因此,通过使用连接的数字健康设备和远程医疗通信,医疗保健,特别是糖尿病护理,正变得更加数字化。因此,有必要将数字数据集成到电子健康记录中,并维护个人数据的机密性、完整性和可用性。将远程医疗与数字连接监测相结合称为虚拟健康。为了使这种虚拟护理模式取得成功,患者必须具备适当的技能、培训和设备。我们提出,除了血压、脉搏、呼吸频率、体温和疼痛这五个当前的生命体征外,此时还应将数字连接视为第六个生命体征。在本文中,我们提出了一个评估数字连接的量表。

相似文献

1
Digital Connectivity: The Sixth Vital Sign.
J Diabetes Sci Technol. 2022 Sep;16(5):1303-1308. doi: 10.1177/19322968211015241. Epub 2021 May 12.
2
Implications of telehealth and digital care solutions during COVID-19 pandemic: a qualitative literature review.
Inform Health Soc Care. 2021 Mar 2;46(1):68-83. doi: 10.1080/17538157.2020.1839467. Epub 2020 Nov 29.
3
Digital technologies in the care of people with diabetes during the COVID-19 pandemic: a scoping review.
Rev Esc Enferm USP. 2021 Nov 24;55:e20210295. doi: 10.1590/1980-220X-REEUSP-2021-0295. eCollection 2021.
8
9
Staying Connected In The COVID-19 Pandemic: Telehealth At The Largest Safety-Net System In The United States.
Health Aff (Millwood). 2020 Aug;39(8):1437-1442. doi: 10.1377/hlthaff.2020.00903. Epub 2020 Jun 11.
10
Validation of telemedicine-based self-assessment of vital signs for patients with COVID-19: A pilot study.
J Telemed Telecare. 2023 Sep;29(8):600-606. doi: 10.1177/1357633X211011825. Epub 2021 May 9.

引用本文的文献

3
Examining Ethnic Disparities in Digital Healthcare Services Utilization: Insights from Israel.
J Multidiscip Healthc. 2023 Nov 17;16:3533-3544. doi: 10.2147/JMDH.S429121. eCollection 2023.
4
Editorial: Application of telehealth to diabetes care delivery and medical training: challenges and opportunities.
Front Endocrinol (Lausanne). 2023 Jun 16;14:1229706. doi: 10.3389/fendo.2023.1229706. eCollection 2023.
7
Telehealth Fatigue: Is It Real? What Should Be Done?
J Diabetes Sci Technol. 2024 Jan;18(1):196-200. doi: 10.1177/19322968221127253. Epub 2022 Oct 7.
8
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study.
J Clin Endocrinol Metab. 2022 Mar 24;107(4):998-1008. doi: 10.1210/clinem/dgab859.
10
Input of Patients for New Diabetes Technology Products.
J Diabetes Sci Technol. 2021 Sep;15(5):983-985. doi: 10.1177/19322968211033611. Epub 2021 Aug 12.

本文引用的文献

2
Patient Preference and Satisfaction with the Use of Telemedicine for Glycemic Control in Patients with Type 2 Diabetes: A Review.
Patient Prefer Adherence. 2021 Feb 10;15:283-298. doi: 10.2147/PPA.S271449. eCollection 2021.
3
Pharmacoadherence: An Opportunity for Digital Health to Inform the Third Dimension of Pharmacotherapy for Diabetes.
J Diabetes Sci Technol. 2021 Jan;15(1):177-183. doi: 10.1177/1932296820973185. Epub 2020 Dec 8.
4
Closing the Digital Health Evidence Gap: Development of a Predictive Score to Maximize Patient Outcomes.
Telemed J E Health. 2021 Sep;27(9):1029-1038. doi: 10.1089/tmj.2020.0334. Epub 2020 Nov 10.
5
REVISITING HEALTH INFORMATION TECHNOLOGY ETHICAL, LEGAL, and SOCIAL ISSUES and EVALUATION: TELEHEALTH/TELEMEDICINE and COVID-19.
Int J Med Inform. 2020 Nov;143:104239. doi: 10.1016/j.ijmedinf.2020.104239. Epub 2020 Jul 31.
6
Determining Physical Activity Characteristics from Wristband Data for Use in Automated Insulin Delivery Systems.
IEEE Sens J. 2020 Nov;20(21):12859-12870. doi: 10.1109/jsen.2020.3000772. Epub 2020 Jun 8.
7
Clouds and Silver Linings: COVID-19 Pandemic Is an Opportune Moment to Democratize Diabetes Care Through Telehealth.
J Diabetes Sci Technol. 2020 Nov;14(6):1107-1110. doi: 10.1177/1932296820963630. Epub 2020 Oct 13.
8
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
N Engl J Med. 2020 Aug 27;383(9):836-845. doi: 10.1056/NEJMoa2004736.
9
The Need for Precision Medicine to be Applied to Diabetes.
J Diabetes Sci Technol. 2020 Nov;14(6):1122-1128. doi: 10.1177/1932296819894295. Epub 2020 Jan 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验